跳至主要内容
临床试验/jRCTs031230070
jRCTs031230070招募中不适用

Multicenter prospective study of attenuated live vaccines for patients using TNF-alfa inhibitors

未提供0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
主要终点
Seropositivity rate of measles

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Prevention Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
1age old over 至 No limit(—)
性别
All

入选标准

  • •(1) Age >= 1 year.
  • •(2) Patients using TNF-alfa inhibitors
  • •(3) Negative or borderline antibody (EIA-IgG < 4.0) against either measles, rubella, varicella or mumps
  • •(4) CD4 cells >= 500/mm3
  • •PHA stimulation index >= 101.6
  • •Serum IgG >= 300mg/dL
  • •(5) PSL<=1mg/day or <=2mg/2days
  • •(6) Disease activity is stable for more than 6 months

排除标准

  • •(1) Patients using other biological agents.
  • •(2) Patients with hematological disease or after bone marrow transplantation.
  • •(3) High disease activity.
  • •(4) Patients under immunoglobulin replacement.
  • •(5) Patients who are planned to receive inactivated VZV vaccine (they cannot receive live varicella vaccine, but can receive MR and mumps vaccine).

结局指标

主要结局

Seropositivity rate of measles

Seropositivity rate after MR vaccination

Seropositivity rate of rubella

Seropositivity rate after MR vaccination

Seropositivity rate of varicella

Seropositivity rate after varicella vaccination

Seropositivity rate of mumps

Seropositivity rate after mumps vaccination

次要结局

未报告次要终点

研究者

发起方
未提供

相似试验